Abbonarsi

Endoscopic morphologic features of ulcerative colitis–associated dysplasia classified according to the SCENIC consensus statement - 20/04/17

Doi : 10.1016/j.gie.2016.11.013 
Shinya Sugimoto, MD 1, Makoto Naganuma, MD, PhD 1, Yasushi Iwao, MD, PhD 2, Katsuyoshi Matsuoka, MD, PhD 1, Masayuki Shimoda, MD, PhD 3, Shuji Mikami, MD, PhD 4, Shinta Mizuno, MD, PhD 1, Yoshihiro Nakazato, MD 5, Kosaku Nanki, MD 1, Nagamu Inoue, MD, PhD 2, Haruhiko Ogata, MD, PhD 5, Takanori Kanai, MD, PhD 1,
1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan 
2 Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan 
3 Department of Pathology, Keio University School of Medicine, Tokyo, Japan 
4 Division of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan 
5 Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan 

Reprint requests: Takanori Kanai, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.Division of Gastroenterology and HepatologyDepartment of Internal MedicineKeio University School of Medicine35 Shinanomachi, Shinjuku-kuTokyo 160-8582Japan

Abstract

Background and Aims

Recent advances in endoscopic equipment and diagnostic techniques have made possible the detection of early dysplasia in the inflamed mucosa of ulcerative colitis (UC). The SCENIC consensus statement recommends the use of unified terminology for the morphology of dysplasia. In this study, we investigated the endoscopic features of high-grade dysplasia (HGD) in a clinical setting.

Methods

We retrospectively identified 62 patients with UC who were diagnosed with colitis-associated cancer or HGD between 1997 and 2015. A total of 39 lesions of HGD detected by targeted biopsy sampling in 31 patients were reviewed, and the endoscopic morphology was classified according to the SCENIC guidelines.

Results

In total, 0 (0%), 6 (15.4%), 19 (48.7%), 12 (30.8%), and 2 (5.1%) lesions with HGD were classified as pedunculated, sessile, superficial elevated, flat, and depressed, respectively. Nearly 80% of the lesions were located in the rectum or sigmoid colon. All flat and depressed lesions were red in color. Typically, sessile/superficial elevated lesions accompanied a flat area (Is+IIb/IIa+IIb). Ulceration was observed in 2 depressed lesions (5.1%). Although the borders were indistinct in 21 lesions (53.8%) without the use of magnifying colonoscopy, all lesions could be distinguished from the surrounding mucosa using magnifying endoscopy.

Conclusions

This is the first study to classify the morphologic features of HGD using the SCENIC guidelines in a clinical setting. Based on our findings, endoscopists should recognize that HGD is frequently associated with a flat/superficial elevated area and red discoloration and should inspect particularly carefully in the rectum and sigmoid colon. The findings of chromoendoscopy and magnifying colonoscopy may also be useful in distinguishing lesions from the surrounding mucosa.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CAC, HGD, SCENIC, UC


Mappa


 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.


© 2017  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 85 - N° 3

P. 639 - marzo 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Classification of nuclear morphology in endocytoscopy of colorectal neoplasms
  • Toyoki Kudo, Shin-ei Kudo, Yuichi Mori, Kunihiko Wakamura, Masashi Misawa, Takemasa Hayashi, Hideyuki Miyachi, Atsushi Katagiri, Fumio Ishida, Haruhiro Inoue
| Articolo seguente Articolo seguente
  • Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool
  • David J. Tate, Lobke Desomer, Amir Klein, Gregor Brown, Luke F. Hourigan, Eric Y.T. Lee, Alan Moss, Donald Ormonde, Spiro Raftopoulos, Rajvinder Singh, Stephen J. Williams, Simon Zanati, Karen Byth, Michael J. Bourke

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.